In one paragraphArticle in JCO precision oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
18 authors.
Yoshiyuki YamamotoDepartment of Urology, The University of Osaka Graduate School of Medicine, Suita, Japan.ORCID 0000-0002-1271-3521 Atsushi KuwaharaNGS Core Facility, Research Institute for Microbial Diseases, The University of Osaka, Suita, Japan.
Atsunari KawashimaDepartment of Urology, The University of Osaka Graduate School of Medicine, Suita, Japan.ORCID 0000-0001-9369-4264 Daisuke MotookaNGS Core Facility, Research Institute for Microbial Diseases, The University of Osaka, Suita, Japan.ORCID 0000-0002-4616-9608 Yoshitake IwamotoDepartment of Urology, The University of Osaka Graduate School of Medicine, Suita, Japan.ORCID 0009-0007-2540-8810 Takehiro YamamotoDepartment of Pathology, The University of Osaka Graduate School of Medicine, Suita, Japan.
Masako KurashigeDepartment of Pathology, The University of Osaka Graduate School of Medicine, Suita, Japan.
Daisuke SakaiCenter for Cancer Genomics and Precision Medicine, Osaka University Hospital, Suita, Japan.ORCID 0000-0002-9436-7553 Yuki HoribeDepartment of Urology, The University of Osaka Graduate School of Medicine, Suita, Japan.
Yu IshizuyaDepartment of Urology, The University of Osaka Graduate School of Medicine, Suita, Japan.
Takuji HayashiDepartment of Urology, The University of Osaka Graduate School of Medicine, Suita, Japan.ORCID 0000-0003-2030-3087 Kentaro TakezawaDepartment of Urology, The University of Osaka Graduate School of Medicine, Suita, Japan.
Koji HatanoDepartment of Urology, The University of Osaka Graduate School of Medicine, Suita, Japan.ORCID 0000-0002-8409-5152 Yoichi KakutaDepartment of Urology, The University of Osaka Graduate School of Medicine, Suita, Japan.ORCID 0000-0001-5339-4312 Taroh SatohCenter for Cancer Genomics and Precision Medicine, Osaka University Hospital, Suita, Japan.ORCID 0000-0002-4615-2638 Eiichi MoriiDepartment of Pathology, The University of Osaka Graduate School of Medicine, Suita, Japan.ORCID 0000-0001-8490-3650 Norio NonomuraDepartment of Urology, The University of Osaka Graduate School of Medicine, Suita, Japan.
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Identifiers
PMID40768676
PMCPMC12337946
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390